Concepedia

Nandini Dey

ND

26

Publications

1.7K

Citations

20

H-Index

2005

Active since

Affiliations

Avera Health(Current)

University of South Dakota

Emory University

University of Sioux Falls

Sanford Research

Nandini Dey is an author at Avera Health specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2005–2023

26

Publications

26

A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity

Joseph R. Garlich, Pradip De, Nandini Dey et al. · Cancer Research · 2008 · 276 citations

Wnt signaling in triple negative breast cancer is associated with metastasis

Nandini Dey, Benjamin G. Barwick, Carlos S. Moreno et al. · BMC Cancer · 2013 · 251 citations · Full text

The Protein Phosphatase Activity of PTEN Regulates Src Family Kinases and Controls Glioma Migration

Nandini Dey, Hal E. Crosswell, Pradip De et al. · Cancer Research · 2008 · 166 citations · Full text

Doubling Down on the PI3K-AKT-mTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness

Pradip De, Yuling Sun, Jennifer Carlson et al. · Neoplasia · 2014 · 105 citations · Full text

ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future.

Brett J. Rozeboom, Nandini Dey, Pradip De · PubMed · 2019 · 73 citations · Full text

, , +19

Rows per page

1–5 of 26